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Improved Cutaneous Healing in Diabetic Mice
Exposed to Healthy Peripheral Circulation
Giorgio Pietramaggiori1,2,3,4, Sandra S. Scherer1,2,4, Michael Alperovich1,2, Bin Chen2, Dennis P. Orgill2 and
Amy J. Wagers1
Impaired repair of skin defects is a major complication of diabetes; yet, the pathophysiology of diabetic (db)
wound healing remains largely opaque. Here, we investigate the role of humoral factors in modulating db
wound repair by generating chimeric animals through parabiotic joining of wild-type (wt) and diabetic (db/db)
mice. This strategy allows wounds on healing-deficient db/db mice to be exposed to factors derived from the wt
circulation at physiologically appropriate concentrations. When compared with db controls, chimeric db/db
animals showed significantly improved healing of full-thickness, cutaneous wounds, with enhanced granulation
tissue formation, angiogenesis, cell proliferation, and collagen deposition. Glycemic control was unaffected by
parabiosis; however, the distribution of circulating leukocytes, altered in db controls, normalized in db-
chimeras. Both wt and db cells were recruited from circulation into db wounds, but wt cells never exceeded
20% of total cells. Improved angiogenesis persisted in db-chimeras separated 24hours after wounding,
suggesting the existence of long-term normalizing factors. This study establishes a new model for studying db
wound healing, and shows a key role for circulating factors in normalizing wound repair in diabetes.
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INTRODUCTION
Several mechanisms have been postulated to explain the
faulty wound healing ability of diabetic patients, including
impaired angiogenesis and inadequate expression of growth
factors at the site of injury (Galiano et al., 2004). Multiple
studies indicate that diabetic cells with critical roles in wound
healing—fibroblasts (Facchiano et al., 2002; Lerman et al.,
2003), macrophages (Waldorf et al., 1984a, b; Amano
et al., 2000; Angelini et al., 2005), neutrophils (Wetzler
et al., 2000), endothelial cells (Loomans et al., 2004; Awad
et al., 2005; Shoji et al., 2006), epithelial cells (Terashi et al.,
2005), and T lymphocytes (Yamashiro et al., 2005)—are
frankly dysfunctional when exposed to a diabetic environ-
ment in vitro. Thus, the impact of diabetes is widespread
and pleiotropic, with complex effects on the majority of cells
and mechanisms involved in the repair process. As a
consequence, although several therapeutic strategies have
been proposed, prevention and metabolic management are
still the best approaches for diabetic ulcers (Falanga, 2005).
Even with tight glycemic control, more than 60% (www.id-
f.org/home/index.cfm) of the non-traumatic lower extremity
amputations performed each year (Falanga, 2005) are among
the diabetic population.
The outcome of cutaneous wound repair likely reflects the
orderly involvement of cellular interactions and global
communications between tissues, rather than simple loca-
lized processes. From this perspective, whole animal
approaches, such as parabiosis, which affords the opportunity
to expose diabetic wounds to physiological levels of wild-
type cells and factors over precise periods of time, offer
distinct experimental advantages in comparison with single-
factor interventions (Steed, 2006). Parabiosis involves the
surgical joining of two immunologically compatible animals
such that they develop a common, anastomosed circulation,
without immune rejection. Cross-circulation typically is
established in parabiotic pairs withinB2–3 days after joining,
with complete blood mixing achieved B5–8 days later
(Wright et al., 2001). As parabiotic animals are connected
solely through their shared peripheral circulation, parabiosis
provides a powerful approach to determine whether blood-
borne factors (either humoral or cellular) can modulate
cutaneous repair. The parabiotic approach has been useful
earlier in revealing the striking ability of circulating factors in
young mice to rejuvenate the muscle regenerative potential
in old animals (Conboy et al., 2005) and of blood-borne
factors in old mice to inhibit the myogenic activity of young
muscle cells (Brack et al., 2007). Parabiosis has also been
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used to investigate the pathophysiology of type 2 diabetes,
and in fact paved the way for the discovery of leptin
(Coleman and Hummel, 1969); however, no previous studies
to our knowledge have exploited this model to investigate the
specific impact of the systemic environment on repair of
cutaneous wounds in diabetic animals.
In this study, we tested whether impaired diabetic wound
healing can be modulated by blood-borne factors in vivo
using a parabiotic system to enable constant exchange of
peripheral blood through the skin microcirculation. Wound
healing deficient (Sullivan et al., 2004; Chan et al., 2006;
Pietramaggiori et al., 2006) diabetic mice (db/db, hereafter
abbreviated db) were joined by parabiosis to normally
healing heterozygous littermates (db/þ , hereafter abbre-
viated wt). Following the establishment of cross-circulation in
the chimeric couples (dbHwt), as well as in wild-type and db
control pairs (wtHwt and dbHdb, respectively), all animals
received full-thickness dermal wounds on the dorsum, which
were monitored for wound healing over 3 weeks, using both
morphological and histological metrics of repair.
RESULTS
The parabiotic model: kinetics of blood exchange and
redistribution of circulating cells
Four-week-old animals were joined in parabiosis before the
clinical onset of diabetes-related wound healing complica-
tions. Under such conditions, all db animals developed the
full db phenotype during parabiosis, regardless of their
parabiotic partners (db or wt). Chimeric and control pairs
were rested 4 weeks after parabiosis surgery to allow for
complete healing of the parabiotic joining wound and for the
establishment of peripheral blood cross-circulation (Figure 1).
To verify the development of cross-circulation between
animals in each parabiotic condition, we examined the
distribution of an intravascular dye (Evan’s Blue) across the
joining wounds. After injection into one animal of the pair,
the Evan’s Blue dye immediately flushed the same animal and
progressively spread through the common vascular tree at the
junction to its partner, as shown by progressive skin
discoloration (Figure 2a). Random pedicled skin flaps were
raised at necropsy revealing anastomosed blood vessels filled
with dye across the junction (Figure 2b). Spectrometry of
serum samples collected from each animal 120minutes after
injection showed full equilibration of the dye in the serum of
both dbHwt chimeras and wtHwt wt control pairs, although
in db dbHdb control pairs the dye concentration in the
uninjected partner was only B50% of the level in the
injected animal at the same time point (Figure 2c).
Exposure to a normal systemic environment improves wound
healing in db parabionts
To study the role of circulating factors in db wound healing,
both parabiotic partners in chimeric or control parabiotic
pairs received full-thickness dorsal skin injuries (Figure 1).
Dorsal wound closure was monitored for each animal by
determining the percent of open wound area—defined as
wound surface not covered by epithelium (Pietramaggiori
et al., 2006)—at 6 discrete time points from 4 to 21 days after
wounding. Quantification of wound closure across study
groups confirmed that wound healing was delayed in db
animals; however, the rate of wound healing in db animals
was strikingly enhanced by parabiosis to a wt partner, as
compared with wound healing in isotypic db control pairs
(dbHdb). This effect was significant at day 7 after wounding,
when control db animals joined to db partners still showed
B75±16% open wound area, whereas db animals joined to
wt partners showed a significantly smaller (44±6%, Po0.01)
open wound (Figure 3a). These data appear to reflect a
beneficial impact of exposure to circulating elements in non-
db mice on the rate of db wound healing. Interestingly,
exposure to circulating factors derived from db mice did not
alter wound closure in wt animals in chimeric pairs (dbHwt)
when compared with wt control pairs (wtHwt). Toward the
end of the follow-up, the natural tendency of db animals to
heal spontaneously by contraction (Pietramaggiori et al.,
2007) obscured the parabiosis-induced differences noted
on day 7.
Increased granulation tissue in heterotypic db parabionts
The formation of granulation tissue is an important early
event for tissue defect filling. Granulation tissue formation
was increased by fourfold (Po0.02) in db animals in a
wounded chimeric setting, as compared with db controls
(dbHdb) (Figure 3b). The amount of granulation tissue in wt
animals in both experimental and control pairs was similar,
and increased when (Po0.01) compared with db animals
(Figure 3b).
Experimental group
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Figure 1. Study design. To study the role of circulating factors in diabetic (db)
and normal (wild type (wt)) wound healing, experimental chimeras were
created by the surgical joining of wt (genotype¼db/þ ) and db
(genotype¼ db/db) animals (n¼ 12 per group). Four-week-old animals were
joined in parabiosis, and the joining wound was allowed to heal. Four weeks
after parabiosis, animals (now 8 weeks old) received a 0.8 cm2 full-thickness
skin wound on the dorsum (pink circle), and wound healing was followed for
a total of 3 weeks after injury.
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Increased collagen deposition in healed wounds of db partners
of wt mice
Three weeks after injury, the wounds on chimeric and control
parabionts showed no macroscopic differences, and all
animals exhibited near-complete wound closure (Figure 3a).
However, significant differences still remained in wound
histology; in wt animals, wounds were filled with collagen—
characterizing the newly formed extracellular matrix—
regardless of their parabiotic partner (wtHdb and wtHwt)
(Figure 3c). In contrast, wounds on db controls (dbHdb)
showed scant collagen deposition and immature organization
(Figure 3c); however, wounds on db partners in chimeric
parabioses (dbHwt) showed significantly greater collagen
deposition in the extracellular matrix as compared with db
controls (dbHdb) (Po0.05), though they were still slightly
less organized than those seen in wt control pairs (Figure 3c
and Figure S1).
Parabiosis to a wt partner increases vascularization and
proliferation in db wounds
During normal wound healing, as during tumor growth, the
availability of blood vessels to deliver nutrients and remove
toxic metabolites is critical to promote cell survival and
enhance cell proliferation. As such, we recently developed
a two-dimensional wound staging system based on
both vascularity and cell proliferation to quantitatively
assess healing (Pietramaggiori et al., 2008). Wound tissues
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Figure 2. Cross-circulation in parabiotic mice. (a) To verify the existence of
cross-circulation between wild-type (wt) and diabetic (db) animals, 4 weeks
after surgical union, one animal in the pair was injected intravenously with
100ml of 0.25% Evan’s Blue (n¼2 per group). The skin of the uninjected
partner showed progressive blue discoloration as illustrated by pictures taken
at the time of injection (0minute), and 60 and 120minutes after injection. (b)
Anastomosed blood vessels stained intensively with the injected dye (arrows)
were found under magnifying loops ( 3) in the subcutaneous tissues. (c) Two
hours after injection, Evan’s Blue concentrations were equalized between the
injected and uninjected partners in wt control pairs and in chimeric pairs
(wtHdb). In contrast, db control pairs (dbHdb) reached only B50%
equivalency in dye distribution.
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Figure 3. Improved kinetics of healing of dorsal wounds in diabetic (db)
animals exposed to a wild-type (wt) systemic milieu. Open wound area
decreased over time in all animals; however, wound healing in db control
pairs (db-control) was generally slower than in wt pairs (wt-control). On day
7, db animals joined to wt partners exhibited significantly increased wound
closure when compared with db-controls (n¼ 12 per group). Results are
shown as mean±SD, *¼Po0.05 for db chimera compared with db control
group. (b) Granulation tissue area increased 3.9-fold under chimeric
parabiotic conditions in db animals (db-chimera) compared with db controls
(db-controls, n¼6 per group). *Po0.05 for comparison indicated. (c)
Collagen deposition is enhanced in db partners of wt mice. Collagen fibrils
were stained on day 21 with Trichrome Masson (n¼ 6 per group). Scale bar
200mm.
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harvested on day 7 were stained for two important markers of
tissue repair: platelet/endothelial cell adhesion molecule
(PECAM-1), a marker of vascular endothelial cells, and Ki-
67, a marker of cell proliferation. Both signals were
significantly enhanced in db partners joined in chimeric
parabiosis (dbHwt), as compared with wounds in db control
pairs (Figure 4a and Figure S2). Wound bed vascularity
(quantified on the basis of the area of PECAM-1 reactivity)
was increased B2-fold in db-chimeras compared with
dbHdb control wounds (P¼ 0.05) (Figure 4a and Figure S2).
In fact, vascularity of wounds in db-chimeras was
similar to that found in wt chimeric partners, although wt
control wounds (from isotypic wtHwt pairs) still showed
higher vascular area when compared with db controls
(Figure 4a and Figure S2) (Po0.01). These data are further
supported by the faster rate of blood exchange that we
observed across the anastomosed vasculature of parabiotic
chimeras, as opposed to db control pairs (Figure 2). Similarly,
PE
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-6
7
Figure 4. Histological analysis shows improved wound healing in diabetic (db) animals. (a) Dorsal wound tissues (n¼6 per group) of diabetic animals
(db-chimera) joined to wild-type (wt) animals exhibited increased levels of vascularization (PECAM-1 staining) and (b) proliferation (Ki-67 staining) compared
with wounds of db controls (db-control).
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the rate of cell proliferation in healing wounds on
db-chimeras was increased 2.6-fold (Po0.01) when
compared with control db pairs (dbHdb) (Figure 4b and
Figure S2), though the proliferative rate was not as high
as the rates typically seen in wt mice. Both wt chimeras
(wtHdb) and wt control pairs (wtHwt) showed greater
(Po0.01) cell proliferation as compared with db control
pairs and a trend toward increased cell proliferation
when compared with db partners in chimeric pairs (dbHwt)
(Figure 4b and Figure S2).
To examine the mechanistic basis for these differences, we
established a second cohort of animals in which the origin of
cells could be tracked. Db/db mice were joined with wt
enhanced green fluorescent protein (eGFP)-transgenic part-
ners (þ /þ ) expressing GFP in all cells and tissues (Wright
et al., 2001). This system allows direct identification of any
wt cell trafficking through the circulation and into the wound
bed in GFP-negative db partners. When chimeric db animals
were joined to eGFPþ wt partners, eGFPþ cells were
detected in the wound area. A subset of these circulation-
derived eGFPþ cells expressed the fibroblast/fibrocyte
marker collagen 1 (Mori et al., 2005), suggesting that wt
fibrocytes may be recruited from the circulation and
participate directly in collagen deposition in the wound area
(Figure 4c).
Wild-type GFPþ cells from circulation contributed only
rarely to blood vessels in db wounds (Figure 4c), suggesting
that the majority of vessel growth in the wound was likely
mediated by host-derived, tissue-resident cells.
To test whether the increased angiogenesis in db-chimeras
corresponded with an increase in expression of chemokines
mediating endothelial progenitor cell recruitment, we in-
vestigated the wound level of expression of stromal cell-
derived factor 1a (SDF-1a). Microcirculation is defective in
db wounds, which typically exhibit a deficient expression of
SDF-1a (Gallagher et al., 2007). This chemokine mediates the
engraftment of endothelial progenitor cells and vasculogen-
esis (Ceradini et al., 2004). Wound tissues harvested from db-
chimera animals showed increased levels of SDF-1a com-
pared with db controls (Figure 4d).
Inflammatory infiltrate and engraftment of wt cells in db
wounds
Immunohistological staining of wound tissues on day 7 with
the pan-hematopoietic marker CD45 showed that db
partners of wt animals exhibited an inflammatory cell
presence equivalent to wt animals (in either control or
chimeric parabiotic pairs). In fact, the frequency of infiltrating
CD45þ cells was fourfold greater in wounds from db
animals joined to wt partners as compared with db
animals joined to db partners (Figure 5a) (Po0.01).
Interestingly, wounds to db-chimeras showed increased
presence of macrophages (F4-80-positive) and T lymphocytes
(Thy 1.2-positive) (Figure S3).
To study more directly the contribution of circulating wt
cells to db wound healing, we next examined by immuno-
fluorescence analysis dorsal wound tissue harvested on day 7
from db partners of eGFP transgenic mice (see above). These
healing wounds showed a mixed representation of GFPþ
and GFP cells. Approximately 20% of the total cells in the
wound area were GFPþ , indicating that they derived from
the wt partner and traveled to the wound bed through the
common circulation of the pair, whereas the remaining 80%
of the cells were GFP, indicating a db origin (Figure 5b).
Analysis of the hematopoietic cell surface marker expression
by cells in these healing wounds showed a similar,
predominantly db origin of inflammatory cells (as assessed
by the pan-leukocyte marker CD45 and the inflammatory cell
marker CD11b) in the wound bed. Only B20% of CD45þ
and CD11bþ cells in the wound bed (Figure 5b) were
derived from the wt partner. Engrafted wt inflammatory cells
in db-chimera wounds were mainly of lymphocytic and
macrophagic origin (Figure 5b).
Effects of heterotypic parabiosis on db metabolism and
circulating blood leukocytes in db mice
To understand whether parabiosis to a healthy partner
affected db metabolism, we evaluated peripheral blood
glycemia as a main metabolic parameter in diabetes.
Surprisingly, parabiosis of db animals to wt partners was
not associated with normalization of peripheral blood
glucose levels. Glucose levels in db animals were consis-
tently hyperglycemic (4550mg per 100ml) throughout the
study, whether these mice were joined in parabiosis with wt
or db partners (Figure 6a). Similarly, wt animals, regardless of
wt-control wt-chimera db-chimera db-control
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Figure 5. Inflammatory infiltrate and engraftment of wild-type (wt) cells in
diabetic (db) wounds. (a) On day 7, wt dorsal wounds showed increased
inflammatory infiltrate (as assessed by CD45 staining) compared with db
controls. The frequency of CD45þ cells was quantified over total nuclei.
Wounds on db-chimera also showed higher inflammatory infiltrate compared
with db controls (n¼ 6 per group). Results are shown as mean±SD, *Po0.05,
for the comparison indicated by brackets. (b) In wounds on the db partner of
chimeric pairs, B20% of the inflammatory infiltrate—CD45 or CD11b-
positive, red staining—was derived from the EGFPþ wt partner. Arrows
indicate EGFPþ (derived from the wt partner) inflammatory cells in db
wounds. Red¼CD45/CD11b; green¼ EGFP; yellow¼ F4-80/Thy 1.2þ EGFP.
Scale bar 40 mm.
www.jidonline.org 2269
G Pietramaggiori et al.
Systemic Regulators of Diabetic Wound Healing
their partners, showed significantly lower blood glucose
(100–130mg per 100ml) than did db animals (Figure 6a,
Po0.01). Circulating insulin levels were similarly regulated,
and were increased in both chimeric and control db animals
as compared with chimeric or control wt animals, with no
differences between the two groups (data not shown). As
cross-circulation clearly exists in db-chimeras (Figure 2),
these results likely reflect the rapid uptake and metabolism of
excess blood glucose and insulin within the wt partner.
To monitor the potential effects of parabiosis on circulat-
ing inflammatory cells, which are key players in wound
repair, we next analyzed circulating leukocyte subsets in
control and chimeric parabionts. One day after injury, the
frequency of distinct lymphoid and myeloid leukocyte
subsets was determined for each experimental group by flow
cytometry. These analyses revealed higher levels of circulat-
ing neutrophils in db control parabionts as compared with wt
controls. It is noted that the representation of neutrophils
(percent of live leukocytes) in the peripheral blood was
significantly decreased in db mice when they were joined to
a wt partner as opposed to joining to a db partner (Figure 6b,
Po0.05). No significant differences were detected in the
circulating levels of monocytes (Figure 6b) or T cells (Figure
6c); however, circulating B-cells in db animals were
significantly increased (Po0.05) in chimeric pairs, as
compared with db animals in control isotypic parabiosis
(Figure 6c).
Previous studies using a similar parabiosis model (Cole-
man, 1982) indicated that parabiosis to db/db partners
decreased food intake in wt parabionts, possibly leading to
their death. In our model, we observed a trend toward
increased leptin levels in the serum of wt partners parabiosed
to db/db mice; however, this trend did not reach statistical
significance (data not shown). Moreover, biopsies from the
gastrointestinal system of chimeric pairs (wtHdb) harvested at
necropsy revealed normotrophic organs in both partners, a
sign of regular feeding (data not shown). In general, animals
in all groups tended to loseB30% of their initial body weight
in the first week after the parabiosis operation (with no
difference between the groups), but the weight of all animals
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Figure 6. Peripheral blood glucose levels do not equalize, but leukocytes normalize in chimeric parabionts. (a) Wild-type animals (wt-chimera and wt-control)
maintain normoglycemia after wounding and throughout the study follow-up, whereas diabetic animals (db-chimera and db-control) were consistently
hyperglycemic, regardless of whether they were joined to diabetic or wt partners (n¼8 per group). (b) Flow cytometry analysis of peripheral blood from animals
in each of the study groups (n¼ 3 per group), performed 1 day after wounding, showed significant differences in the frequency of circulating neturophils in db
chimeric animals (db-chimera) as compared with db controls (db-control). *Indicates Po0.05 for comparison of db-control animals to each of the other groups.
Differences between wt-control, wt-chimera, and db-chimera groups were not significant (P40.05). No differences were detected in the circulating levels of
monocytes (Mac1þGr1/lo) (Lagasse and Weissman, 1996). (c) Circulating B cell levels were higher in wt animals when compared when db controls. Joining to
a wt partner increased circulating B220þ B-cell levels in db chimeras (db-chimera) as compared with db control animals (db-control) (n¼3 per group).
*Indicates Po0.05 for comparison of db-control animals with each of the other groups. Differences between wt-control, wt-chimera, and db-chimera groups
were not significant (P40.05). No differences were seen in circulating CD3þ T-cell numbers between db control (db-control) and db chimeras (db-chimera).
(d and e) After wounding, although the plasma levels of tumor necrosis factor-a in db-chimera increased, reaching the levels of wt animals, the opposite trend
was seen for cholesterol (n¼6 per group). Results are shown as mean±SD, *¼ Po0.05 for comparison of wt-control, wt-chimera, or db-chimera groups with
the db-control group (d), or Po0.05 for the db-control group compared with wt-control, wt-chimera, or the db-chimera groups (e).
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stabilized before the start of the dorsal wound healing study
(data not shown). Evaluation of other inflammatory and
metabolic mediators revealed significant changes in tumor
necrosis factor-a and cholesterol levels as a result of
heterotypic parabiosis. Tumor necrosis factor-a levels were
2.5-fold higher in db-chimeras, as compared with db-
controls, and in fact reached levels comparable to those of
wt-animals (Figure 6d). In contrast, cholesterol levels showed
an opposite response, and were decreased by B0.7-fold in
db-chimeras (Figure 6e).
Persistence of improved wound healing in separated db
parabionts
To assess the persistence of the rehabilitating effects of
parabiosis on db wound healing, a subset of experimental
and control pairs were joined at 4 weeks of age, rested 4
weeks, wounded, and then separated 24hours after wounding
(Figure 7a, n¼6). In this cohort, dorsal wounds on day 7
showed only a trend toward increased wound closure (data not
shown); however, the vascularization of these wounds on db-
chimeras was significantly increased compared with db
controls (Figure 7b). In addition, long-term maintenance of at
least some of these recruited wt cells was also apparent in db
wounds of animals that were separated 24hours after
wounding (Figure 7c). The majority of these circulation-derived
cells exhibited expression of CD11b, or collagen I (Figure 7c),
indicating a hematopoietic or fibrocytic lineage commitment.
DISCUSSION
In this study, we generated a chimera in which db/db and wt
mice were joined solely through their cutaneous microcircu-
lation. These experiments were motivated by the question
whether healthy blood-borne factors may modulate the
pathophysiology of db wound healing.
Intriguingly, we found that heterotypic parabiosis did not
affect glycemic control, but did modulate clinically relevant
metrics of wound healing in db partners of wt animals.
Parabiosis to a wt partner caused significant improvements
in wound closure of db mice, which were evident at day 7
after wounding. Enhanced granulation tissue formation,
collagen deposition, and increased angiogenesis and cell
proliferation in healing wounds distinguished wounds on db-
chimera from db control. Effects were most robust in pairs
joined for several weeks, but some changes were also noted
in pairs separated 24 hours after wounding, suggesting that
improved wound healing through heterotypic parabiosis may
not require continuous, long-term systemic exchange.
In the circulation of chimeric db animals, we observed
normalization of leukocyte frequencies and of several
inflammatory and metabolic parameters, such as tumor
necrosis factor-a and cholesterol, but surprisingly we saw
no effects on glycemia or circulating insulin levels. Finally,
using eGFP wt partners, we showed that at most 20% of the
total cells were derived from the wt partner.
Diabetic chimeras showed a relative decrease in the levels
of circulating mature neutrophils (which were low also in
wound tissues (Wetzler et al., 2000)) and an increase
in circulating B cells. These changes in circulation
corresponded to an increased engraftment of macrophages
and lymphocytic cells in the wound tissue and increased
SDF-1a expression. These results suggest interesting simila-
rities between aging and diabetes. Previous studies have
shown an age-dependent deficit in the ability of transplanted
hematopoietic stem cells from old mice to give rise to
peripheral B-lymphocytes, coincident with an increased
myelopoietic activity (Rossi et al., 2005). Thus, it is
interesting to speculate that alterations in peripheral blood
leukocyte subsets in db animals may result from alterations
in hematopoietic stem cell function similar to those observed
Skin
injury
Experimental group
Chimera wt  : : db
: db
: wt
Control groups
Diabetic
Wild type
4 week old
= Histology
Parabiosis
24 hours days 7, 21
Euthanasia
*
wt-control wt-chimera db-chimera db-control
80
60
40
20
0
Bl
oo
d 
ve
ss
e
ls
/H
PF
db  :
wt :
Figure 7. Long-term effect of parabiosis. (a) To study the effects of long-term
engraftment on wound healing, parabiotic couples (n¼ 6 per group), prepared
as described earlier, were separated 24 hours after wounding. (b) Dorsal
wounds on diabetic chimeras showed increased vasculature compared with
diabetic controls on day 7. Results are shown as mean±SD, *¼ Po0.05 for
the comparison indicated by brackets. (c) Diabetic animals, joined earlier in
parabiosis with EGFP expressing wild-type partners and separated 24 h after
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of EGFPþ cells still expressing CD11b and Collagen I. Scale bar 40mm.
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with aging. Additional studies will clearly be required
to understand the importance of these similarities in
aged and db patient populations, both of which are
characterized by some degree of healing impairment
(Ashcroft et al., 1995).
In experiments in which parabiotic pairs were separated
soon after wounding, we still observed a noticeable stimula-
tion of angiogenesis in separated db-chimera animals. These
results from separation studies suggest that important
contributions from the wt partners take place even within
the first 24 hours after wounding, which is consistent with the
timing of inflammatory cell recruitment and encouraging
with regard to the clinical applicability of these findings.
We were surprised to see no changes in glycemia as a
consequence of parabiosis, as glucose control remains the
main approach to optimize wound healing in the clinical
arena (Falanga, 2005). These results indicate that the primary
mechanism by which parabiotic exposure to circulating
factors in a normal mouse improves impairments in db
wound healing is not through normalization of the db
metabolism.
The db mouse has long served as an experimental model
of human type 2 diabetes (Sullivan et al., 2004; Chan et al.,
2006; Pietramaggiori et al., 2006). Previous parabiosis studies
using this model described early death of the wt partner of db
animals; however, in these early studies additional vascular
anastomosis and surgical union of the celiac walls (generat-
ing a unique abdominal cavity) likely induced a massive
exposure to leptin and/or mechanical compression of the
abdominal cavity (Fruhbeck and Gomez-Ambrosi, 2001) that
was not observed in our studies in which the skin alone was
joined. It will be interesting in future studies to explore other
models of experimentally induced diabetes, such as the
streptozocin-induced type 1 model, using the same para-
biotic system to better understand how cutaneous wound
healing may be similarly or differentially affected in response
to different disease etiologies.
In conclusion, to our knowledge, our studies establish
parabiosis as a previously unreported experimental platform
for the investigation of db wound repair, and point to key
glucose-independent regulators that may be altered by
diabetes to impair appropriate responses to cutaneous tissue
damage.
MATERIALS AND METHODS
Animals
Homozygous genetically db (Goldblum et al., 1983) 4-week-old
Lep/r – db/db (strain C57BL/KsJ-Leprdb) female mice were joined in
parabiosis with their age-matched wt (Ramsey et al., 1999)
littermates db/þ , both obtained from Jackson Laboratories
(Bar Harbor, ME) (www.jax.org) (n¼ 12 per group). In some studies,
B6 db/db mice (background strain C57BL/6J) were used instead of
Lep/r –db/db, and these were joined with non-db C57BL/Ka-EGFP
transgenic partners (Wright et al., 2001) to allow tracking of wt cells
in db tissues in vivo (n¼ 6). A subset of animals (n¼ 6) were joined
as described above and separated 24 hours after wounding. All
animals were used under approved animal protocols and housed at
the Joslin Diabetes Center animal facility.
Parabiosis
Parabiotic pairs (experimental chimeras dbHwt, wt controls wtHwt,
or db controls dbHdb; n¼ 12 per group) were generated by surgical
union of the dorsal and ventral skin along the corresponding lateral
surface of age-matched animals as described earlier (Figure 1)
(Conboy et al., 2005).
Assessment of cross-circulation
Four weeks after the parabiosis operation, a subset (n¼ 2 couples) of
animals from each study condition was used for confirming the
presence of cross-circulation of blood. One animal in each couple was
injected with 100ml of Evan’s Blue into the retro-orbital venous plexus.
Peripheral blood was collected before injection, and 120minutes after
injection, from each animal and serum dye concentration was
quantified through spectrometry. Photographs of the animals were
taken at 30, 60, 90, and 120minutes after injection. Once the blood
was collected for analysis, random pedicled skin flaps were raised
across the junction to visualize blood vessel anastomosis 2hours after
injection; the concentration of Evan’s Blue in the serum of each partner
was measured using a NanoDrop spectrophotometer (Thermo Fisher
Scientific Inc., Waltham, MA).
Skin injury
Thirty days after the parabiosis operation, each animal in the pair
received a dorsal, 0.8 cm2, full-thickness skin wound (Jacobi et al.,
2002). On the day before the surgery, the hair was clipped and
depilated (Nair, Church & Dwight Co., Princeton, NJ). On the day of
the surgery, animals were weighed and anesthetized with 15 ml g1
of 2.5% Avertin solution, and the wounds were excised and dressed
with a clear, semipermeable polyurethane membrane (Tegaderm
dressing, Nexcare, 3M, St Paul, MN). Standardized photographs of
the dorsal wounds of all animals were taken twice a week, and
wound closure (quantified as reduction of raw area as a percentage
of the original wound area, as shown earlier (Pietramaggiori et al.,
2006, 2007)) as quantified using digital planimetry methods (Image J,
NIH, Bethesda, MD) for a total follow-up of 21 days (Michaels et al.,
2005). Tissues were harvested on day 7 (n¼ 6 per group) or day 21
(n¼ 6 per group) and wounds with surrounding tissue were
harvested en bloc, fixed in 10% formalin, and stored in 70%
alcohol at 41C until the central wound cross-sections were
embedded in paraffin. Histological cross-sections were stained
according to routine hematoxylin and eosin and Trichrome Masson’s
protocols. Panoramic cross-sectional digital images of each wound
were prepared using Adobe Photoshop CS Software (Adobe Systems
Incorporated, San Jose, CA). Hematoxylin and eosin stained sections
were analyzed with digital planimetry (Image J, NIH) by two
independent observers, blinded to experimental condition, to
quantify the area of granulation tissue.
Immunohistochemistry
Paraffin-embedded sections (n¼ 6 per group) were stained for ki-67
(Dako Corp., Carpinteria, CA), PECAM-1 (Pharmingen, San Jose,
CA), CD 45 (Pharmingen, San Jose, CA), and SDF-1 (Abcam Inc.,
Cambridge, MA) mAbs as shown earlier (Pietramaggiori et al., 2006,
2007). Frozen sections were incubated with rat anti-mouse CD11b,
CD45, CD31, CD3, CD8, F4-80, and Thy 1.2 mAbs (Pharmingen,
San Jose, CA) and rabbit anti-mouse collagen type I polyclonal
antibody (Chemicon, Temecula, CA). Frozen sections were
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incubated with TEX-Red conjugated donkey anti-rat (Jackson
ImmunoResearch Laboratories, West Grove, PA) or rabbit (Accurate
Chemical & Scientific Corporation, Westbury, NY) secondary
antibody for 1 hour at room temperature. Sections were stained
with DAPI (Invitrogen, Eugene, OR) prior mounting and examined
using an Olympus BX51 fluorescent microscope (Olympus Inc.,
Tokyo, Japan).
Wound healing staging system
Wound healing was staged by a two-dimensional staging system
based on the immunolocalization of the vascular area (positive for
PECAM-1) and proliferating cells (positive for ki-67) as shown earlier
(Pietramaggiori et al., 2006). In PECAM-1-stained slides, the vascular
area (positive for PECAM-1) was analyzed using  40 magnification.
Using  40 magnification Trichrome Masson’s stained slides, the
same methodology was used for the quantification of collagen
deposition (blue areas) on day 21. In Ki-67 stained slides, the ratio of
proliferating nuclei (positive for Ki-67) over total nuclei was
quantified using  40 magnification. Eighteen microscopic fields
at  40 magnification were used in each treatment arm and
immunolocalization condition.
Metabolic parameters
Morning collections of peripheral blood were performed during
the follow-up. Blood glucose concentration was measured twice a
week between 0800 and 0830 hours, using a glucose meter (Lifescan
Inc., Milpitas, CA). The Elisa kits were used to measure plasma
Insulin, Leptin (Crystal Chem Inc., Downers Grove, IL) and
tumor necrosis factor-a (Invitrogen, Carlsbad, CA) and cholesterol
levels with an enzymatic-colorimetric system (Stanbio Laboratory,
Boerne, TX).
Flow cytometry of peripheral blood
One day after wounding, peripheral blood was collected from the
tail vein of each animal in each experimental condition. Nucleated
peripheral blood leukocytes were isolated from whole blood
following ammonium chloride-mediated lysis of red blood cells.
Cells were then stained using a cocktail of antibodies to detect blood
lineage markers (including CD3 (145-2C11, Cy7PE conjugate), CD4
(GK1.5, Cy7PE conjugate), CD8 (53-6.7, Cy7PE conjugate), B220
(RA3-6B2), Mac1 (M1/70, APC conjugate), and Gr1 (RB6-8C5),
(neutrophils, Mac1þGr1hi) (Lagasse and Weissman, 1996) (all from
eBioscience, San Diego, CA), and analyzed by flow cytometry for
expression of each leukocyte marker. Data were collected using a
multiparameter BD LSR II flow cytometer (BD Biosciences, San Jose,
CA) and analyzed offline using FlowJo software (Treestar Inc.,
Ashland, OR). Phenotypic markers used for identification of each
leukocyte subset are indicated in the figure legend.
Statistical analysis
Data are presented as mean±SD in the text and figures. One-way
analysis of variance and ad hoc LSD tests were used to determine the
differences between experimental groups. Multivariate analysis was
performed using Statistica v7.0 (StatSoft Inc., Tulsa, OK). A P-value
of 0.05 was considered significant.
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